Apolipoprotein A-I helical structure and stability in discoidal high-density lipoprotein (HDL) particles by hydrogen exchange and mass spectrometry. 2012

Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
Lipid Research Group, Gastroenterology, Hepatology and Nutrition Division, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4318, USA.

To understand high-density lipoprotein (HDL) structure at the molecular level, the location and stability of α-helical segments in human apolipoprotein (apo) A-I in large (9.6 nm) and small (7.8 nm) discoidal HDL particles were determined by hydrogen-deuterium exchange (HX) and mass spectrometry methods. The measured HX kinetics of some 100 apoA-I peptides specify, at close to amino acid resolution, the structural condition of segments throughout the protein sequence and changes in structure and stability that occur on incorporation into lipoprotein particles. When incorporated into the large HDL particle, the nonhelical regions in lipid-free apoA-I (residues 45-53, 66-69, 116-146, and 179-236) change conformation from random coil to α-helix so that nearly the entire apoA-I molecule adopts helical structure (except for the terminal residues 1-6 and 237-243). The amphipathic α-helices have relatively low stability, in the range 3-5 kcal/mol, indicating high flexibility and dynamic unfolding and refolding in seconds or less. A segment encompassed by residues 125-158 exhibits bimodal HX labeling indicating co-existing helical and disordered loop conformations that interchange on a time scale of minutes. When incorporated around the edge of the smaller HDL particle, the increase in packing density of the two apoA-I molecules forces about 20% more residues out of direct contact with the phospholipid molecules to form disordered loops, and these are the same segments that form loops in the lipid-free state. The region of disc-associated apoA-I that binds the lecithin-cholesterol acyltransferase enzyme is well structured and not a protruding unstructured loop as reported by others.

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D016632 Apolipoprotein A-I The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. Apo A-I,Apo A-1,Apo A-I Isoproteins,Apo A1,Apo AI,ApoA-1,ApoA-I,Apolipoprotein A-1,Apolipoprotein A-I Isoprotein-2,Apolipoprotein A-I Isoprotein-4,Apolipoprotein A-I Isoproteins,Apolipoprotein A1,Apolipoprotein AI,Apolipoprotein AI Propeptide,Pro-Apo A-I,Pro-Apolipoprotein A-I,Proapolipoprotein AI,Apo A I Isoproteins,Apolipoprotein A 1,Apolipoprotein A I,Apolipoprotein A I Isoprotein 2,Apolipoprotein A I Isoprotein 4,Apolipoprotein A I Isoproteins,Pro Apo A I,Pro Apolipoprotein A I
D017433 Protein Structure, Secondary The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation. Secondary Protein Structure,Protein Structures, Secondary,Secondary Protein Structures,Structure, Secondary Protein,Structures, Secondary Protein
D041961 Deuterium Exchange Measurement A research technique to measure solvent exposed regions of molecules that is used to provide insight about PROTEIN CONFORMATION. Hydrogen-Deuterium Exchange Measurement,Deuterium Exchange Measurements,Exchange Measurement, Deuterium,Exchange Measurement, Hydrogen-Deuterium,Exchange Measurements, Deuterium,Exchange Measurements, Hydrogen-Deuterium,Hydrogen Deuterium Exchange Measurement,Hydrogen-Deuterium Exchange Measurements,Measurement, Deuterium Exchange,Measurement, Hydrogen-Deuterium Exchange,Measurements, Deuterium Exchange,Measurements, Hydrogen-Deuterium Exchange
D055550 Protein Stability The ability of a protein to retain its structural conformation or its activity when subjected to physical or chemical manipulations. Protein Stabilities,Stabilities, Protein,Stability, Protein

Related Publications

Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
February 2017, Nature structural & molecular biology,
Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
December 1992, The Journal of biological chemistry,
Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
June 2007, Biochemistry,
Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
September 2002, Biochemistry,
Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
July 2003, The Journal of biological chemistry,
Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
June 2010, The journal of physical chemistry. B,
Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
January 2006, Biochemistry,
Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
November 1999, The Journal of biological chemistry,
Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
November 1990, The Journal of biological chemistry,
Palaniappan Sevugan Chetty, and Leland Mayne, and Zhong-Yuan Kan, and Sissel Lund-Katz, and S Walter Englander, and Michael C Phillips
May 2009, Protein science : a publication of the Protein Society,
Copied contents to your clipboard!